BIOADAPTIVES INC - BDPT STOCK NEWS

BioAdaptives (OTC: BDPT) announces strategic shift with five new nutritional products planned for phased market entry over 6-9 months, following James Keener's appointment as CEO in May 2024. The first product, Zeranovia, targets weight management. The company claims preliminary test results show effectiveness comparable to prescription medications with fewer side effects. BioAdaptives has applied for Institutional Review Board (IRB) approval to conduct human clinical trials, an uncommon step for nutraceutical companies, aiming to validate their product's effectiveness through medically supervised proof.

BioAdaptives (OTC: BDPT) announces a complete overhaul of its product portfolio, replacing all legacy products with new scientifically advanced nutritional solutions. The new lineup includes products for weight management, wellness, muscle and tissue repair, and anti-aging for both humans and Paw Partners. Each product has been developed through extensive research and customer feedback, focusing on superior performance and sustainability. The company will introduce products individually, with the first launches expected within weeks, supported by a dedicated customer service team.

BioAdaptives (OTC: BDPT) addresses an inadvertent early release of shareholder information regarding an upcoming reverse stock split. The company explains that since January 2020, outstanding shares increased by 6,530% from 18.5 million to 1.23 billion as of June 2024, without corresponding revenue growth. New management, led by CEO James Keener, plans to implement the reverse split alongside a business transformation strategy that includes launching several new products, establishing new distribution channels, and improving marketing efforts with enhanced packaging.

BioAdaptives (OTC: BDPT) announces the appointment of Gimhana Dissanayake to its Board of Directors. Dissanayake, currently the VP of Operational Sales for North America at Hertz (NYSE: HTZ), brings over 20 years of experience in strategic growth and operational excellence. He has been key in enhancing the market presence of Hertz, Dollar, and Thrifty brands and has formed significant partnerships with Fortune 500 companies. His academic background includes degrees from Oklahoma State University, California State University, Sacramento, and executive education from Cornell and Wharton. The appointment is expected to bolster BioAdaptives' growth and innovation in the wellness sector.

BioAdaptives, Inc. (BDPT) introduces NaturaComplete™, an All-In-One Dietary Supplement formula containing over 70 nutrients to support general health and obesity management. The formula aims to provide bioavailable nutrients, protein building blocks, and promote immune defense and healing. It is designed to enhance body appearance by reducing body fat mass and addressing issues like muscle loss and hair loss.

BioAdaptives, Inc. (BDPT) announces a new, Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Loss Reported with Obesity Management. The app offers immediate, cost-effective, personalized assessments of body fat and muscle mass, along with tracking capabilities that can support any obesity or fitness regimen. The rising popularity of GLP-1 medications for treating obesity has spurred significant advancements in the development of more efficacious drugs and supplements. However, further studies are necessary to ascertain the potential side effects of these novel medications. The app enables users to conveniently monitor their body fat and muscle mass metrics.

BioAdaptives, Inc. (BDPT) has signed a new non-exclusive Distributor’s Agreement with Pixelcando S.L., Tenerife, Spain, for the AI-supported FIT YOUR OUTFIT (FYO) body composition smartphone App. The agreement allows BioAdaptives to market the technology in the US directly to retail individual clients and organizations such as weight management/nutritional and fitness companies, sports teams, spas, health professionals, and senior communities. The FYO App utilizes AI to scientifically measure body composition with a single photo from a smartphone and provides advanced body composition analysis, progress monitoring, and is accompanied by the introduction of new health products for weight management, health, wellness, and fitness. The global body composition analyzer and weight loss app market is projected to grow to US$1.4 billion in 2027 and to US$2.6 billion by 2030.

BioAdaptives Inc. (BDPT) launches a specialized R&D Food Lab to create natural powder products and treats for animal and human consumption. The new facility aims to support holistic health solutions and the weight management AI BodyShape Division. The Food Lab will focus on developing high-quality, natural powder supplement formulations utilizing Traditional Chinese Medicine and Ayurvedic Culture ingredients. The company aims to expand its product line and provide accessible nutrition options for everyone in the family, including pets.

BioAdaptives Inc. (OTC: BDPT) announces the formation of a new business division, AI BodyShape Lab, in January 2024 to promote adult fitness and weight management. The division will optimize BioAdaptives’ patented, AI-based ‘Fit Your Outfit’ smartphone application and provide dietary information, suggested meal replacements, and exercises for adults. The CEO, Edward Jacobs, M.D., emphasizes the importance of identifying deep, internal, abdominal fat and its impact on overall body shape and health conditions like diabetes and cardiovascular disease. The new division aims to provide education and comprehensive services to support a healthier lifestyle.